Thoracic Imaging

What’s the Best Initial Imaging for an Immunocompromised Patient with a Cough?

·
What's the Best Initial Imaging for an Immunocompromised Patient with a Cough?

It’s 3 AM in the emergency department, and you’re evaluating a 58-year-old woman undergoing chemotherapy for breast cancer who presents with a new cough, fever, and shortness of breath. Her absolute neutrophil count is low. You know that a pulmonary process in an immunocompromised host can progress rapidly, and the differential diagnosis is broad and dangerous. Your immediate question is what imaging to order first to guide management. This article provides a detailed clinical workflow for this exact scenario, focusing on the crucial first step in the diagnostic pathway. For the initial imaging of an immunocompromised patient with acute respiratory illness, the American College of Radiology (ACR) Appropriateness Criteria rate a chest radiograph as “Usually Appropriate.”

Who Fits This Clinical Scenario?

This guidance applies to a specific and high-risk patient population: individuals with compromised immune systems presenting with new-onset respiratory symptoms. The defining features include:

  • Immunocompromised State: This includes patients with neutropenia (e.g., from chemotherapy), solid organ or hematopoietic stem cell transplant recipients, those with advanced HIV/AIDS, or individuals on long-term high-dose corticosteroids or other potent immunosuppressive agents.
  • Acute Respiratory Symptoms: The presentation is characterized by the recent onset of cough, dyspnea (shortness of breath), chest pain, or fever where a pulmonary source is suspected.
  • Initial Imaging Decision: This workflow is for the first imaging study ordered for this presentation. The patient has not yet had imaging for this specific episode.

This guidance does not apply to patients who have already had a chest radiograph for this illness. If the initial radiograph is normal, equivocal, or shows only nonspecific findings, that constitutes a different clinical question. Similarly, if the radiograph is clearly abnormal with diffuse opacities, the next steps in imaging follow a separate decision pathway. This article is strictly about selecting the correct test at the very beginning of the workup.

What Diagnoses Are You Working Up in This Scenario?

The differential diagnosis for respiratory illness in an immunocompromised patient is extensive and includes both infectious and non-infectious etiologies. The initial imaging is intended to narrow this list and detect urgent pathology. Key considerations include:

Bacterial Pneumonia: This remains a primary concern and can be caused by typical community-acquired pathogens (e.g., Streptococcus pneumoniae) or opportunistic organisms (e.g., Pseudomonas aeruginosa, Nocardia). The presentation can range from a focal lobar consolidation to a more diffuse pattern, and prompt identification is critical for initiating appropriate antibiotic therapy.

Fungal Pneumonia: This is a life-threatening possibility, particularly in certain types of immunosuppression. Invasive aspergillosis is a major concern in severely neutropenic patients or stem cell transplant recipients and can manifest as nodules, sometimes with surrounding ground-glass opacity (the “halo sign”). Pneumocystis jirovecii pneumonia (PJP) is a classic consideration in patients with impaired T-cell immunity (e.g., AIDS, high-dose steroids) and typically presents with diffuse, bilateral interstitial or ground-glass opacities.

Viral Pneumonia: Viruses like Cytomegalovirus (CMV), respiratory syncytial virus (RSV), and influenza can cause severe pneumonia in this population. Radiographic findings are often nonspecific, ranging from normal to diffuse interstitial changes or multifocal consolidation, making clinical and microbiologic correlation essential.

Non-Infectious Processes: The differential must also include causes unrelated to infection. Pulmonary edema, whether cardiogenic or non-cardiogenic (e.g., Acute Respiratory Distress Syndrome – ARDS), can mimic pneumonia. Other possibilities include diffuse alveolar hemorrhage, which can be seen in transplant patients or those with coagulopathy, and drug-induced pneumonitis from chemotherapy or other medications.

Why Is a Chest Radiograph the Recommended Initial Study?

For the initial evaluation of an immunocompromised patient with acute respiratory symptoms, the ACR designates a chest radiograph as “Usually Appropriate.” This recommendation is based on a careful balance of diagnostic utility, accessibility, speed, and safety.

A standard two-view (posteroanterior and lateral) chest radiograph is the cornerstone of initial thoracic imaging. It is highly effective at detecting significant parenchymal disease, such as lobar consolidation, large nodules, or extensive diffuse opacities. It can also readily identify complications like pleural effusions or pneumothorax. Its widespread availability, low cost, and rapid acquisition make it the ideal first-line test to quickly triage the patient and guide immediate clinical decisions, such as starting empiric antimicrobial therapy or admitting the patient to a higher level of care.

The radiation dose is extremely low (adult relative radiation level ☢ <0.1 mSv), which is an important consideration in patients who may require serial imaging throughout their illness.

Why are other studies rated lower for the initial step?

  • CT chest without or with IV contrast is rated “May be appropriate.” While CT is significantly more sensitive than radiography for subtle ground-glass opacities, small nodules, or early interstitial changes, it is not the recommended first test. It delivers a substantially higher radiation dose (☢☢☢ 1-10 mSv) and is best reserved for situations where the chest radiograph is negative or inconclusive but clinical suspicion for a serious pulmonary process remains high. Starting with CT for every patient would lead to unnecessary radiation exposure and resource utilization.
  • MRI chest is rated “Usually not appropriate.” MRI has a very limited role in the evaluation of lung parenchymal infections. It is susceptible to motion artifacts from breathing and cardiac motion, and its spatial resolution for the fine details of the lung interstitium is inferior to CT. It is not a suitable screening or initial diagnostic tool for suspected pneumonia in this setting.

The choice to start with a chest radiograph is a strategic one. It efficiently answers the first critical question: is there a clear, actionable finding? If so, treatment can begin. If not, the negative or equivocal result then justifies the escalation to a more sensitive, higher-radiation modality like CT.

What’s Next After a Chest Radiograph? Downstream Workflow

The results of the initial chest radiograph dictate the subsequent clinical and diagnostic pathway. The goal is to move from a broad differential to a specific diagnosis and treatment plan.

If the radiograph is clearly positive (e.g., lobar consolidation, large effusion):
The immediate next step is to initiate empiric therapy targeted at the most likely pathogens based on the patient’s specific immune defect, exposure history, and the radiographic pattern. Concurrently, efforts should be made to obtain a microbiologic diagnosis via sputum culture, blood culture, or urinary antigen testing. If the patient does not respond to initial therapy or if a more specific diagnosis is needed to guide treatment (e.g., suspected fungal vs. bacterial cause), bronchoscopy with bronchoalveolar lavage (BAL) is often the next procedure.

If the radiograph is negative, equivocal, or shows only nonspecific findings:
This is a critical juncture. A normal chest radiograph does not rule out significant early pulmonary disease in an immunocompromised patient. If there is a high clinical suspicion for pneumonia (e.g., persistent fever, hypoxia, severe neutropenia), the next step is to proceed to a more sensitive imaging study. This aligns with the sibling ACR scenario, “Acute respiratory illness in immunocompromised patients. Normal, equivocal, or nonspecific chest radiograph.” In this case, a non-contrast CT of the chest is typically the next appropriate test to look for subtle ground-glass opacities, micronodules, or other findings not visible on the plain film.

If the radiograph is abnormal with diffuse, confluent opacities:
This finding raises strong concern for PJP, ARDS, viral pneumonia, or pulmonary hemorrhage. Management involves aggressive respiratory support and broad empiric antimicrobial coverage. This clinical picture also routes to a different ACR variant focused on the workup of diffuse disease, where CT and potentially bronchoscopy play a central role.

Pitfalls to Avoid (and When to Get Help)

Navigating this scenario requires vigilance to avoid common diagnostic traps. Here are several pitfalls specific to the initial workup:

  • Stopping the workup after a negative chest radiograph: In a symptomatic, high-risk immunocompromised patient, a normal radiograph is not a definitive “all clear.” Maintain a low threshold to escalate to CT if clinical suspicion persists.
  • Underestimating the breadth of the differential: Do not anchor prematurely on a diagnosis of simple bacterial pneumonia. Always consider opportunistic fungi, viruses, and non-infectious mimics in your differential.
  • Delaying empiric therapy: While awaiting definitive imaging or microbiology results, do not delay the initiation of broad-spectrum antimicrobial therapy in a clinically unstable patient. These infections can progress with alarming speed.
  • Ignoring the patient’s specific immune defect: The most likely pathogens vary dramatically based on the type of immunosuppression (e.g., neutropenia vs. T-cell defect vs. humoral defect). Tail your differential and empiric therapy accordingly.

If the patient exhibits rapid clinical deterioration, profound hypoxia, or hemodynamic instability, escalate immediately to a critical care specialist and consider expedited, advanced imaging and invasive diagnostic procedures like bronchoscopy.

Related ACR Topics and Tools

The ACR Appropriateness Criteria are a living resource, and understanding the context of this specific scenario is key. For a comprehensive overview of all related clinical variants, from follow-up imaging to workup of non-infectious disease, please consult our parent guide. Additional GigHz tools can help you apply these guidelines in your daily practice.

Frequently Asked Questions

Why not just order a CT scan first for everyone since it’s more sensitive?

While a CT scan is more sensitive, a chest radiograph is recommended as the initial test because it provides a rapid, low-cost, and very low-radiation assessment that can often identify the problem. Starting with a chest radiograph avoids unnecessary radiation and cost in cases where the diagnosis is clear on the plain film. A CT is reserved for cases where the radiograph is negative or inconclusive despite high clinical suspicion.

If the patient is neutropenic, does that change the initial imaging choice?

No, the initial imaging choice remains a chest radiograph, regardless of the specific type of immunocompromise, including neutropenia. However, the patient’s neutropenic state significantly influences the differential diagnosis (raising concern for fungal infections like Aspergillus) and lowers the threshold to proceed to a CT scan if the initial radiograph is unrevealing.

Should I order a portable chest x-ray instead of a two-view study in the department?

A two-view (PA and lateral) chest radiograph performed in the radiology department is always superior to a single-view portable (AP) study. However, if the patient is too unstable to be transported, a portable radiograph is an acceptable alternative for the initial assessment. Be aware that portable films are less sensitive and can be limited by patient positioning and technique.

Is there any role for ultrasound in this initial workup?

Point-of-care lung ultrasound (POCUS) is an emerging tool that can be useful at the bedside, particularly for detecting pleural effusions, large consolidations, and B-lines suggestive of edema. However, it is highly operator-dependent and is not considered a replacement for a formal chest radiograph as the standard initial imaging test according to the ACR criteria for this scenario.

Does IV contrast help for the initial evaluation of suspected pneumonia?

For the initial evaluation of a suspected pulmonary infection, IV contrast is generally not necessary and a non-contrast CT is sufficient. Contrast may be added if there is a specific concern for a vascular complication like a pulmonary embolism, a suspected mediastinal abscess, or to better characterize a complex pleural effusion (empyema), but it is not required for the primary goal of identifying parenchymal inflammation or infection.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 26, 2026